DOPPLER ANALYZER
FOR CARDIOVASCULAR ACTIVITY OF MOTHER AND FETUS
High-tech screening
designed for quick and accurate fetal assessment
device during pregnancy.
1.5 - 3 minutes to detect an abnormal state of the fetus
Service lifetime is 5 years. Warranty and post-warranty service
Automatic documentation or transfer of the result over the Internet
В1.5 - 3 minutes to detect an abnormal state of the fetus
Service lifetime is 5 years. Warranty and post-warranty service
Automatic documentation or transfer of the result over the Internet
DOPPLER ANALYZER
FOR CARDIOVASCULAR ACTIVITY OF MOTHER AND FETUS ADMP-02
High-tech screening device designed for quick and accurate fetal assessment during pregnancy.
1.5 - 3 minutes to detect an abnormal state of the fetus
Service lifetime is 5 years. Warranty and post-warranty service
Automatic documentation or transfer of the result over the Internet
REDUCES PERINATAL AND INFANT MORTALITY
Increases the birth rate of upstanding children
Learn more
It is possible to prevent deaths and reduce morbidity by identifying and addressing the causes of intrauterine fetal distress.
Identifying the intrauterine fetal distress in the early stages of pregnancy and, most importantly, in the stage of ambulatory penetral care, including before-doctor stage, allows taking appropriate measures in time and thereby reduce the risk of perinatal death.
Today, most of these issues are identified only at the stage of a pregnant woman's admission to the hospital, that is, at the stage of childbirth, which leads to a high possibility of a birth of unviable children.
REDUCES PERINATAL AND INFANT MORTALITY
Increases the birth rate of upstanding children
Learn more
It is possible to prevent deaths and reduce morbidity by identifying and addressing the causes of intrauterine fetal distress.
Identifying the intrauterine fetal distress in the early stages of pregnancy and, most importantly, in the stage of ambulatory penetral care, including before-doctor stage, allows taking appropriate measures in time and thereby reduce the risk of perinatal death.
Today, most of these issues are identified only at the stage of a pregnant woman's admission to the hospital, that is, at the stage of childbirth, which leads to a high possibility of a birth of unviable children.
REDUCES PERINATAL AND INFANT MORTALITY
Increases the birth rate of upstanding children
Learn more
It is possible to prevent deaths and reduce morbidity by identifying and addressing the causes of intrauterine fetal distress.
Identifying the intrauterine fetal distress in the early stages of pregnancy and, most importantly, in the stage of ambulatory penetral care, including before-doctor stage, allows taking appropriate measures in time and thereby reduce the risk of perinatal death.
Today, most of these issues are identified only at the stage of a pregnant woman's admission to the hospital, that is, at the stage of childbirth, which leads to a high possibility of a birth of unviable children.
IMPLEMENTATION EXAMPLES AND FEEDBACK
CLINICAL TRIALS RESULTS OF AT FSBI NATIONAL RESEARCH CENTER FOR OBSTETRICS, GYNECOLOGY AND PERINATOLOGY NAMED AFTER ACADEMICIAN V.I.KULAKOV
“There are no alternatives in the speed rate of the fetal assessment at the present stage. The device is simple and reliable to operate. It can be used everywhere even only by a nurse-midwife and with an option to document the received data on the built-in printer".
Head of the Department of Visual Diagnostics, M.D. Voevodin Sergei M.
RESULTS OF CLINICAL APPROBATION ADMP-02 AT PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY
“The results obtained with the help of ADMP-02 had all the necessary and sufficient information content. The device is easy to use, can operate off-line a long time and does not require special training of medical and nursing personnel. The presented type of the device is easily treated with detergents and disinfectants."
Professor of the Obstetrics and gynecology department of Pavlov First Saint Petersburg State Medical University, Chief Obstetrician and Gynecologist of Saint Petersburg, B.N. Novikov
RESULTS OF 2 YEARS OF OPERATION OF ADMP-02 DEVICE IN THE TULA REGIONAL PERINATAL CENTER
“For the reporting period, 3753 cardiocotography recordings were carried out using the Analyzer ADMP-02 of 022 modification. 258 disabilities of the intrauterine state of the fetus were revealed. All patients with identified disabilities were admitted to the pathologic pregnancy department for further examination and treatment. There we no perinatal losses in this group”.
Chief Medical Officer of State Health Institution “Tula Regional Perinatal Center”, E.A. Kozina
CLINICAL TRIALS RESULTS OF AT FSBI NATIONAL RESEARCH CENTER FOR OBSTETRICS, GYNECOLOGY AND PERINATOLOGY NAMED AFTER ACADEMICIAN V.I.KULAKOV
“There are no alternatives in the speed rate of the fetal assessment at the present stage. The device is simple and reliable to operate. It can be used everywhere even only by a nurse-midwife and with an option to document the received data on the built-in printer".
Head of the Department of Visual Diagnostics, M.D. Voevodin Sergei M.
RESULTS OF CLINICAL APPROBATION ADMP-02 AT PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY
“The results obtained with the help of ADMP-02 had all the necessary and sufficient information content. The device is easy to use, can operate off-line a long time and does not require special training of medical and nursing personnel. The presented type of the device is easily treated with detergents and disinfectants."
Professor of the Obstetrics and gynecology department of Pavlov First Saint Petersburg State Medical University, Chief Obstetrician and Gynecologist of Saint Petersburg, B.N. Novikov
RESULTS OF 2 YEARS OF OPERATION OF ADMP-02 DEVICE IN THE TULA REGIONAL PERINATAL CENTER
“For the reporting period, 3753 cardiocotography recordings were carried out using the Analyzer ADMP-02 of 022 modification. 258 disabilities of the intrauterine state of the fetus were revealed. All patients with identified disabilities were admitted to the pathologic pregnancy department for further examination and treatment. There we no perinatal losses in this group”.
Chief Medical Officer of State Health Institution “Tula Regional Perinatal Center”, E.A. Kozina
CLINICAL TRIALS RESULTS OF AT FSBI NATIONAL RESEARCH CENTER FOR OBSTETRICS, GYNECOLOGY AND PERINATOLOGY NAMED AFTER ACADEMICIAN V.I.KULAKOV
“There are no alternatives in the speed rate of the fetal assessment at the present stage. The device is simple and reliable to operate. It can be used everywhere even only by a nurse-midwife and with an option to document the received data on the built-in printer".
Head of the Department of Visual Diagnostics, M.D. Voevodin Sergei M.
RESULTS OF CLINICAL APPROBATION ADMP-02 AT PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY
“The results obtained with the help of ADMP-02 had all the necessary and sufficient information content. The device is easy to use, can operate off-line a long time and does not require special training of medical and nursing personnel. The presented type of the device is easily treated with detergents and disinfectants."
Professor of the Obstetrics and gynecology department of Pavlov First Saint Petersburg State Medical University, Chief Obstetrician and Gynecologist of Saint Petersburg, B.N. Novikov
RESULTS OF 2 YEARS OF OPERATION OF ADMP-02 DEVICE IN THE TULA REGIONAL PERINATAL CENTER
“For the reporting period, 3753 cardiocotography recordings were carried out using the Analyzer ADMP-02 of 022 modification. 258 disabilities of the intrauterine state of the fetus were revealed. All patients with identified disabilities were admitted to the pathologic pregnancy department for further examination and treatment. There we no perinatal losses in this group”.
Chief Medical Officer of State Health Institution “Tula Regional Perinatal Center”, E.A. Kozina
ENABLES EXPENSIVE USE
OF AVAILABLE EXPENSIVE
DIAGNOSTIC TOOLS MORE EFFICIENTLY
What is the use of the device?
For a doctor:
With the help of the device doctor can diagnose the condition of the fetus in the early stages of pregnancy, identify intrauterine fetal death or intrauterine fetal distress. This allows the doctor to:
- to carry out additional diagnostics and the necessary therapy measures in time, which makes it possible to implement the principle - “a child must be born not only alive, but also healthy”;
- preventing a medical error due to forthcoming and correct diagnosis;
- ecure oneself against legal
prosecution by the state and / or
the patient (his relatives); - improvement of working conditions (hygienic and physical related).
For the director of a healthcare facility:
For Russia, this is a new medical technology aimed at reducing perinatal morbidity and mortality and improving the health of the Russian population. The widespread use of the device in medical practice, in combination with other methods, will allow:
- to reduce perinatal losses;
- to ensure an increase of the healthy children birth rates - annually a number of healthy children born will be equal to a city population;
- to reduce the cost of nursing and treatment of difficult to nurse for and sick children;
- to decrease the disablement rates of the population;
- to reduce the possibility of medical error and litigations;
- to create more comfortable working conditions for doctors.
What economic benefits will be achieved?
Reducing perinatal and maternal morbidity is one of the most significant economic indicators as it leads to quantity reduction of occupied in-patient beds and to the decrease of the costs for nursing and treatment of the children and mothers. It also provides the decrease of sickness benefits and disablement payouts. The number of the able-bodied population will be increasing, which in return creates additional material assets.
According to the Federal target program «Children of Russia» (2007-2010), with a decrease in infant mortality to 8.8 per 1000 live births, maternal mortality to 20.5 per 100 thousand live births, under-fours mortality rate (inclusive) - up to 10.9 per 1000 newborns of the relevant year of birth will give an economic benefit of about 19 billion rubles.
Reference: in 2016, 1,859,854 babies were delivered.
What tasks are being solved:
- Starting from 12-14 weeks of pregnancy, determination of the presence of a fetal heartbeat starting from 12-14 weeks of pregnancy.
- Starting from 15-16 weeks of pregnancy, determination of the fetal heart rate (HR) with the help of a digital display.
- Starting from 26 weeks of pregnancy, determination of the heart rate main characteristics and automatic comparison of them with the normal range.
- Listening to the heartbeat and specific blood flow sounds in human vessels based on ultrasonography data.
- Determination of the placenta location.
- Diagnosis of multifetal pregnancy.
Learn more on how to improve diagnostic efficiency
Order a manager’s consulting service
- The data is securely protected. You will not receive mailings and notifications.
What is the use of the device?
For a doctor:
With the help of the device doctor can diagnose the condition of the fetus in the early stages of pregnancy, identify intrauterine fetal death or intrauterine fetal distress. This allows the doctor to:
- to carry out additional diagnostics and the necessary therapy measures in time, which makes it possible to implement the principle - “a child must be born not only alive, but also healthy”;
- preventing a medical error due to forthcoming and correct diagnosis;
- ecure oneself against legal
prosecution by the state and / or
the patient (his relatives); - improvement of working conditions (hygienic and physical related).
For the director of a healthcare facility:
For Russia, this is a new medical technology aimed at reducing perinatal morbidity and mortality and improving the health of the Russian population. The widespread use of the device in medical practice, in combination with other methods, will allow:
- to reduce perinatal losses;
- to ensure an increase of the healthy children birth rates - annually a number of healthy children born will be equal to a city population;
- to reduce the cost of nursing and treatment of difficult to nurse for and sick children;
- to decrease the disablement rates of the population;
- to reduce the possibility of medical error and litigations;
- to create more comfortable working conditions for doctors.
What economic benefits will be achieved?
Reducing perinatal and maternal morbidity is one of the most significant economic indicators as it leads to quantity reduction of occupied in-patient beds and to the decrease of the costs for nursing and treatment of the children and mothers. It also provides the decrease of sickness benefits and disablement payouts. The number of the able-bodied population will be increasing, which in return creates additional material assets.
According to the Federal target program «Children of Russia» (2007-2010), with a decrease in infant mortality to 8.8 per 1000 live births, maternal mortality to 20.5 per 100 thousand live births, under-fours mortality rate (inclusive) - up to 10.9 per 1000 newborns of the relevant year of birth will give an economic benefit of about 19 billion rubles.
Reference: in 2016, 1,859,854 babies were delivered.
What tasks are being solved:
- Starting from 12-14 weeks of pregnancy, determination of the presence of a fetal heartbeat starting from 12-14 weeks of pregnancy.
- Starting from 15-16 weeks of pregnancy, determination of the fetal heart rate (HR) with the help of a digital display.
- Starting from 26 weeks of pregnancy, determination of the heart rate main characteristics and automatic comparison of them with the normal range.
- Listening to the heartbeat and specific blood flow sounds in human vessels based on ultrasonography data.
- Determination of the placenta location./li>
- Diagnosis of multifetal pregnancy.
Learn more on how to improve diagnostic efficiency
Order a manager’s consulting service
- Все данные надёжно защищены от спама и рассылок.
What is the use of the device?
For a doctor:
With the help of the device doctor can diagnose the condition of the fetus in the early stages of pregnancy, identify intrauterine fetal death or intrauterine fetal distress. This allows the doctor to:
- to carry out additional diagnostics and the necessary therapy measures in time, which makes it possible to implement the principle - “a child must be born not only alive, but also healthy”;
- preventing a medical error due to forthcoming and correct diagnosis;
- ecure oneself against legal
prosecution by the state and / or
the patient (his relatives); - improvement of working conditions (hygienic and physical related).
For the director of a healthcare facility:
For Russia, this is a new medical technology aimed at reducing perinatal morbidity and mortality and improving the health of the Russian population. The widespread use of the device in medical practice, in combination with other methods, will allow:
- to reduce perinatal losses;
- to ensure an increase of the healthy children birth rates - annually a number of healthy children born will be equal to a city population;
- to reduce the cost of nursing and treatment of difficult to nurse for and sick children;
- to decrease the disablement rates of the population;
- to reduce the possibility of medical error and litigations;
- to create more comfortable working conditions for doctors.
What economic benefits will be achieved?
Reducing perinatal and maternal morbidity is one of the most significant economic indicators as it leads to quantity reduction of occupied in-patient beds and to the decrease of the costs for nursing and treatment of the children and mothers. It also provides the decrease of sickness benefits and disablement payouts. The number of the able-bodied population will be increasing, which in return creates additional material assets.
According to the Federal target program «Children of Russia» (2007-2010), with a decrease in infant mortality to 8.8 per 1000 live births, maternal mortality to 20.5 per 100 thousand live births, under-fours mortality rate (inclusive) - up to 10.9 per 1000 newborns of the relevant year of birth will give an economic benefit of about 19 billion rubles.
Reference: in 2016, 1,859,854 babies were delivered.
What tasks are being solved:
- Starting from 12-14 weeks of pregnancy, determination of the presence of a fetal heartbeat starting from 12-14 weeks of pregnancy.
- Starting from 15-16 weeks of pregnancy, determination of the fetal heart rate (HR) with the help of a digital display.
- Starting from 26 weeks of pregnancy, determination of the heart rate main characteristics and automatic comparison of them with the normal range.
- Listening to the heartbeat and specific blood flow sounds in human vessels based on ultrasonography data.
- Determination of the placenta location.
- Diagnosis of multifetal pregnancy.
Learn more on how to improve diagnostic efficiency
Order a manager’s consulting service
- Все данные надёжно защищены от спама и рассылок.
DEVICE FEATURES
+
Fetal heart rate recording
+
Availability of an internal memory
+
Rechargeable battery
+
Availability of a LCD display
+
Printing of a finished analysis
+
Three-colour display
+
Date and time storage function
+
PC synchronization
+
High accuracy of values
+
Internal speaker
+
Comparison of indicators
+
Eco-friendly casing material
+
Fetal heart rate recording
+
High accuracy of values
+
Internal speaker
+
Comparison of indicators
+
Availability of an internal memory
+
Rechargeable battery
+
Availability of a LCD display
+
Printing of a finished analysis
+
Three-colour display
+
Date and time storage function
+
PC synchronization
+
Eco-friendly casing material
TECHNICAL SPECIFICATION
| Probe for determining fetal heart rate in the early stages (12-14 weeks), MHz | 2 |
| Fetal heart rate (FHR) measurement range, b/min | 50-220 |
| Display | LCD |
| Fetal assessment display | three-colour display |
| Recharging device | 220-240 V |
| Ultrasound radiation intensity, mV / cm2 | less than 10 |
| Average examination time, min. | 1,5-2 |
| Number of examinations before recharging is needed | no less than 40 |
| Warranty period, months | 12 |
| Service lifetime | 5 years |
| Continuous operation period | 2 hours |
| Operation period in doctor mode | 8 hours |
| Overall dimensions of the device with the Basic unit (BRZ), mm | 200х220х110 |
| Overall dimensions of the device, mm (* fits in the pocket of the robe) | 150х100х25 |
| Weight of the device | 350 g |
| Probe for determining fetal heart rate in the early stages (12-14 weeks), MHz | 2 |
| Fetal heart rate (FHR) measurement range, b/min | 50-220 |
| Display | LCD |
| Fetal assessment display | three-colour display |
| Recharging device | 220-240 V |
| Ultrasound radiation intensity, mV / cm2 | less than 10 |
| Average examination time, min. | 1,5-2 |
| Number of examinations before recharging is needed | no less than 40 |
| Warranty period, months | 12 |
| Service lifetime | 5 years |
| Continuous operation period | 2 hours |
| Operation period in doctor mode | 8 hours |
| Overall dimensions of the device with the Basic unit (BRZ), mm | 200х220х110 |
| Overall dimensions of the device, mm (* fits in the pocket of the robe) | 150х100х25 |
| Weight of the device | 350 g |
MODIFICATIONS
Start
Model 02 Basic model
-
Audio output - speaker 1W + Stereo wired headset
-
Display - Liquid-crystal display
-
Power supply - rechargeable battery 9 V 250 mAh (300 charge / discharge cycles)
-
Ultrasound signal: frequency - 2 MHz, intensity - 5 mW / cm2
-
Duration of autonomous continuous operation- 4 hours
-
Automatic charger
-
Responsiveness - 12 weeks of pregnancy
-
Built-in analysis programme
-
Display of the analysis results on the liquid crystal digital display
-
Fetal assessment display- LED (green, yellow, red)
-
Automatic shutdown after 5 min. work, after 40 sec without a signal
-
Ultrasound gel 1 bottle 250 ml
Profi
Model 021 With additional features
-
Audio output - speaker 1W + Stereo wired headset
-
Display - Liquid-crystal display
-
Power supply - rechargeable battery 9 V 250 mAh (300 charge / discharge cycles)
-
Ultrasound signal: frequency - 2 MHz, intensity - 5 mW / cm2
-
Duration of autonomous continuous operation- 4 hours
-
Automatic charger
-
Responsiveness - 12 weeks of pregnancy
-
Built-in analysis programme
-
Display of the analysis results on the liquid crystal digital display
-
Fetal assessment display- LED (green, yellow, red)
-
Automatic shutdown after 5 min. work, after 40 sec without a signal
-
Ultrasound gel 1 bottle 250 ml
-
Internal memory up for 35 patients with 215 Predicted Maximum Heart Rate values
-
Multiprocessor registration and charging analysis unit with printer
-
5 rolls of thermal printer ribbon
Advanced
Model 022 With the maximum number of features
-
Audio output - speaker 1W + Stereo wired headset
-
Display - Liquid-crystal display
-
Power supply - rechargeable battery 9 V 250 mAh (300 charge / discharge cycles)
-
Ultrasound signal: frequency - 2 MHz, intensity - 5 mW / cm2
-
Duration of autonomous continuous operation- 4 hours
-
Automatic charger
-
Responsiveness - 12 weeks of pregnancy
-
Built-in analysis programme
-
Display of the analysis results on the liquid crystal digital display
-
Fetal assessment display- LED (green, yellow, red)
-
Automatic shutdown after 5 min. work, after 40 sec without a signal
-
Ultrasound gel 1 bottle 250 ml
-
Internal memory up for 35 patients with 215 Predicted Maximum Heart Rate values
-
Multiprocessor registration and charging analysis unit with printer
-
5 rolls of thermal printer ribbon
-
Unit for communication between the device and computer
-
Computer programme for analysis, archiving and protocol printing
MODIFICATIONS
Start
Model 02 Basic model
-
Audio output - speaker 1W + Stereo wired headset
-
Display - Liquid-crystal display
-
Power supply - rechargeable battery 9 V 250 mAh (300 charge / discharge cycles)
-
Ultrasound signal: frequency - 2 MHz, intensity - 5 mW / cm2
-
Duration of autonomous continuous operation- 4 hours
-
Automatic charger
-
Responsiveness - 12 weeks of pregnancy
-
Built-in analysis programme
-
Display of the analysis results on the liquid crystal digital display
-
Fetal assessment display- LED (green, yellow, red)
-
Automatic shutdown after 5 min. work, after 40 sec without a signal
-
Ultrasound gel 1 bottle 250 ml
Profi
Model 021 With additional features
-
Audio output - speaker 1W + Stereo wired headset
-
Display - Liquid-crystal display
-
Power supply - rechargeable battery 9 V 250 mAh (300 charge / discharge cycles)
-
Ultrasound signal: frequency - 2 MHz, intensity - 5 mW / cm2
-
Duration of autonomous continuous operation- 4 hours
-
Automatic charger
-
Responsiveness - 12 weeks of pregnancy
-
Built-in analysis programme
-
Display of the analysis results on the liquid crystal digital display
-
Fetal assessment display- LED (green, yellow, red)
-
Automatic shutdown after 5 min. work, after 40 sec without a signal
-
Ultrasound gel 1 bottle 250 ml
-
Internal memory up for 35 patients with 215 Predicted Maximum Heart Rate values
-
Multiprocessor registration and charging analysis unit with printer
-
5 rolls of thermal printer ribbon
Advanced
Model 022 With the maximum number of features
-
Audio output - speaker 1W + Stereo wired headset
-
Display - Liquid-crystal display
-
Power supply - rechargeable battery 9 V 250 mAh (300 charge / discharge cycles)
-
Ultrasound signal: frequency - 2 MHz, intensity - 5 mW / cm2
-
Duration of autonomous continuous operation- 4 hours
-
Automatic charger
-
Responsiveness - 12 weeks of pregnancy
-
Built-in analysis programme
-
Display of the analysis results on the liquid crystal digital display
-
Fetal assessment display- LED (green, yellow, red)
-
Automatic shutdown after 5 min. work, after 40 sec without a signal
-
Ultrasound gel 1 bottle 250 ml
-
Internal memory up for 35 patients with 215 Predicted Maximum Heart Rate values
-
Multiprocessor registration and charging analysis unit with printer
-
5 rolls of thermal printer ribbon
-
Unit for communication between the device and computer
-
Computer programme for analysis, archiving and protocol printing
ВЫГОДНЫЕ УСЛОВИЯ ЗАКУПКИ
Получите актуальный прайс-лист
Узнайте о действующих акциях и скидках
- Все данные надёжно защищены. Вам не будут приходить какие-либо рассылки.
Получите актуальный прайс-лист
Узнайте о действующих акциях и скидках
- Все данные надёжно защищены. Вам не будут приходить какие-либо рассылки.
Получите актуальный прайс-лист
Узнайте о действующих акциях и скидках
- Все данные надёжно защищены.
